cardiovascular benefits of glp 1 agonists GLP-1 receptor and outcome trials: An update Glucagon-like peptide-1 (GLP-1) receptor agonists

Rogler, G

Our studies on glutathione and NAFLD have shown very significant results that may be patented for normalization of liver enzymes and reduction of inflammation markers

Serious but rare risks: Tissue irritation if injected incorrectly or if compounded solution is too alkaline

Patients should bring their full medical history and medication list to any consultation so the risk discussion is specific, not generic

PMID: 28762014 DOI: 10.1007/s10555-017-9675-z Patrignani P et al (2014): Reappraisal of the clinical pharmacology of low-dose aspirin by comparing novel direct and traditional indirect biomarkers of drug action